PMC:7394275 / 20077-20735 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue
T296	147-153	UBERON:0007023	denotes	adults
T297	381-395	CHEBI:2682;CHEBI:2682	denotes	amphotericin B
T298	415-426	CHEBI:5100;CHEBI:5100	denotes	flucytosine
T299	440-451	CHEBI:46081;CHEBI:46081	denotes	fluconazole
T300	477-488	CHEBI:46081;CHEBI:46081	denotes	fluconazole
T301	491-502	CHEBI:5100;CHEBI:5100	denotes	flucytosine
T302	506-520	CHEBI:2682;CHEBI:2682	denotes	amphotericin B
T303	521-533	CHEBI:23614;CHEBI:23614	denotes	deoxycholate
T304	536-547	CHEBI:46081;CHEBI:46081	denotes	fluconazole
T305	578-589	CHEBI:46081;CHEBI:46081	denotes	fluconazole
T306	646-657	CHEBI:46081;CHEBI:46081	denotes	fluconazole
T89127	147-153	UBERON:0007023	denotes	adults
T93441	381-395	CHEBI:2682;CHEBI:2682	denotes	amphotericin B
T94698	415-426	CHEBI:5100;CHEBI:5100	denotes	flucytosine
T49658	440-451	CHEBI:46081;CHEBI:46081	denotes	fluconazole
T9605	477-488	CHEBI:46081;CHEBI:46081	denotes	fluconazole
T18149	491-502	CHEBI:5100;CHEBI:5100	denotes	flucytosine
T36092	506-520	CHEBI:2682;CHEBI:2682	denotes	amphotericin B
T79474	521-533	CHEBI:23614;CHEBI:23614	denotes	deoxycholate
T28968	536-547	CHEBI:46081;CHEBI:46081	denotes	fluconazole
T44295	578-589	CHEBI:46081;CHEBI:46081	denotes	fluconazole
T89336	646-657	CHEBI:46081;CHEBI:46081	denotes	fluconazole

Id	Subject	Object	Predicate	Lexical cue	fma_id
T66	134-137	Body_part	denotes	HIV	http://purl.org/sig/ont/fma/fma278683
T67	245-248	Body_part	denotes	hiv	http://purl.org/sig/ont/fma/fma278683

Id	Subject	Object	Predicate	Lexical cue	tao:has_database_id
595	172-180	Species	denotes	children	Tax:9606
596	245-248	Species	denotes	hiv	Tax:12721
597	381-408	Chemical	denotes	amphotericin B deoxycholate	MESH:C059765
598	415-426	Chemical	denotes	flucytosine	MESH:D005437
599	440-451	Chemical	denotes	fluconazole	MESH:D015725
600	477-488	Chemical	denotes	fluconazole	MESH:D015725
601	491-502	Chemical	denotes	flucytosine	MESH:D005437
602	506-520	Chemical	denotes	amphotericin B	MESH:D000666
603	521-533	Chemical	denotes	deoxycholate	MESH:D003840
604	536-547	Chemical	denotes	fluconazole	MESH:D015725
605	578-589	Chemical	denotes	fluconazole	MESH:D015725
606	646-657	Chemical	denotes	fluconazole	MESH:D015725
607	110-130	Disease	denotes	cryptococcal disease	MESH:D016919
608	134-146	Disease	denotes	HIV-infected	MESH:D015658
609	264-284	Disease	denotes	cryptococcal-disease	MESH:D016919

Id	Subject	Object	Predicate	Lexical cue
T123	184-188	http://purl.obolibrary.org/obo/CLO_0001185	denotes	2018
T124	205-217	http://purl.obolibrary.org/obo/OBI_0000245	denotes	Organization
T125	285-287	http://purl.obolibrary.org/obo/CLO_0037161	denotes	en
T126	394-395	http://purl.obolibrary.org/obo/CLO_0001021	denotes	B
T127	519-520	http://purl.obolibrary.org/obo/CLO_0001021	denotes	B

Id	Subject	Object	Predicate	Lexical cue	chebi_id
T115	285-287	Chemical	denotes	en	http://purl.obolibrary.org/obo/CHEBI_30347
T116	381-395	Chemical	denotes	amphotericin B	http://purl.obolibrary.org/obo/CHEBI_2682
T117	396-408	Chemical	denotes	deoxycholate	http://purl.obolibrary.org/obo/CHEBI_23614
T118	415-426	Chemical	denotes	flucytosine	http://purl.obolibrary.org/obo/CHEBI_5100
T119	440-451	Chemical	denotes	fluconazole	http://purl.obolibrary.org/obo/CHEBI_46081
T120	477-488	Chemical	denotes	fluconazole	http://purl.obolibrary.org/obo/CHEBI_46081
T121	491-502	Chemical	denotes	flucytosine	http://purl.obolibrary.org/obo/CHEBI_5100
T122	506-520	Chemical	denotes	amphotericin B	http://purl.obolibrary.org/obo/CHEBI_2682
T123	521-533	Chemical	denotes	deoxycholate	http://purl.obolibrary.org/obo/CHEBI_23614
T124	536-547	Chemical	denotes	fluconazole	http://purl.obolibrary.org/obo/CHEBI_46081
T125	578-589	Chemical	denotes	fluconazole	http://purl.obolibrary.org/obo/CHEBI_46081
T126	592-595	Chemical	denotes	iii	http://purl.obolibrary.org/obo/CHEBI_74062
T127	646-657	Chemical	denotes	fluconazole	http://purl.obolibrary.org/obo/CHEBI_46081

Id	Subject	Object	Predicate	Lexical cue
T102	0-290	Sentence	denotes	The treatment recommendations can be supported by guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents, and children in 2018 by World Health Organization (from: https://www.who.int/hiv/pub/guidelines/cryptococcal-disease/en/).
T103	291-658	Sentence	denotes	Generally, the following is recommended as the preferred regimen: (i) Induction phase for amphotericin B deoxycholate and + flucytosine, followed by fluconazole; alternative options for fluconazole + flucytosine or amphotericin B deoxycholate + fluconazole. (ii) Consolidation phase for fluconazole. (iii) Maintenance (or secondary prophylaxis) phase for fluconazole.